Lecturer
University of Leeds
Leeds, England, United Kingdom
Dr Cédric Duval, PhD, Leeds Institute of Cardiovascular and Metabolic Medicine.
I gained my PhD from the University of Liverpool in 2007, working on the regulation of uPA by H. pylori in the gastric epithelium, and joined my current Institute in 2010.
My research interests are on the role of FXIII and fibrin clot structure on thromboembolism, with the development of relevant animal and technical models. Specifically, I am looking at the FXIIIA-V34L variant (Duval et al, ATVB, 2016), and fibrinogen mutants where the a-chain or g-chain crosslinking is abolished (Duval et al, PNAS, 2021), and their effect on thrombus structure, stability and embolisation in-vitro and in-vivo.
In 2023, I have been awarded a British Heart Foundation Intermediate Fellowship looking into the role of FXIII-A and its V34L variant in thromboinflammation.
Sunday, June 25, 2023
15:00 – 15:15 ET
OC 53.6 - Fibrinolysis and Novel Strategies
Tuesday, June 27, 2023
10:45 – 12:00 ET
PB1193 - Acute myocardial infarction thrombi show fibrin film that increases with ischaemia duration
Tuesday, June 27, 2023
18:30 – 19:30 ET
PB1223 - EkoSonic Endovascular System promotes thrombolysis by altering fibrin fibre thickness
Tuesday, June 27, 2023
18:30 – 19:30 ET